Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Of Cabbages and Rings—AD and the Vasculature
1 September 2005. Two recent reports add to the growing evidence that trouble in the circulatory system can lead to cognitive impairment and Alzheimer disease (AD). Ben Wolozin and colleagues report in the latest issue of the Journal of Alzheimer’s Disease that coronary artery bypass grafts (CABG), commonly known as “cabbages,” increase the risk for developing AD postsurgery, while Rudi Westendorp and colleagues report in the September issue of the journal Radiology that poor cerebral blood flow correlates with dementia in the elderly.

Wolozin, at Boston University, together with colleagues at Pfizer in Groton, Connecticut, and Northwestern University, the University of Chicago, and that VA Hospital in Hines, all in Illinois, followed over 5,000 patients who had undergone the CABG procedure between October 1996 and September 1997. First author Todd Lee and colleagues found that 119 of the patients developed AD during the five years following their operation. As a control, they also followed patients (just over 3,900 individuals) who had undergone angioplasty (percutaneous transluminal coronary angioplasty or PTCA). The relative risk for AD in the CABG group was almost twice that in the PTCA group—1.7-fold. The findings confirm previously documented postoperative cognitive decline in much smaller groups of patients following CABG surgery (see Selnes et al., 2001 and Newman et al., 2001). The analysis “demonstrates that there is a significant association between CABG surgery and subsequent cognitive decline, as demonstrated by the incidence of AD, when compared to a cohort undergoing PTCA,” write the authors.

Why the CABG procedure should increase the risk for AD is not entirely clear, but Lee and colleagues suggest that it could be due to an exacerbated decrease in cognitive, or neuronal, reserve. Neuronal reserve has been used to explain why a loss of brain matter can be more devastating to some than to others (see Buckner, 2004), and could be compromised by hypoperfusion during surgery (see ARF Live Discussion on the vascular hypothesis of AD).

The role of hypoperfusion in late-onset dementia is supported by the second paper. Using magnetic resonance imaging, Westendorp and colleagues at Leiden University, The Netherlands, measured total cerebral blood flow in a group of 48 volunteers, made up of 15 young, 16 elderly with optimal cognition, and 17 elderly patients with dementia (the study was first published online July 12). First author Aart Spilt and colleagues found that although those elderly volunteers who still retained optimal cognition had reduced blood flow compared to the younger group (551 mL/min versus 742 mL/min), those elderly with dementia fared even worse, having an average total cerebral blood flow of only 443 mL/min. The data are even more dramatic given that subjects with any vascular dementia, which would presumably skew the data toward even lower blood flow measurements in the dementia group, were excluded from the study.—Tom Fagan.

Reference:
Lee TA, Wolozin B, Weiss KB, Bednar MM. Assessment of the emergence of Alzheimer’s disease following coronary artery bypass graft surgery or percutaneous transluminal coronary angioplasty. J. Alzheimer’s Disease. August 2005;7:319-324. Abstract

Spilt A, Weverling-Rijnsburger AWE, Middelkoop HAM, van Der Flier WM, Gussekloo J, de Craen AJM, Bollen ELEM, Blauw GJ, van Buchem MA, Westendorp RGJ. Late-onset dementia: structural brain damage and total cerebral blood flow. Radiology. 2005;236:990-995. Abstract

 
Comments on News and Primary Papers
  Comment by:  Mary Reid
Submitted 1 September 2005  |  Permalink Posted 12 September 2005

Is it possible that coronary artery bypass grafting was more likely complicated by atrial fibrillation requiring digoxin therapy in those who later developed AD?

I refer to my previous post in which I ask whether digoxin therapy may be a risk factor for the development of AD (see ARF related news story).

The reduced cerebral blood flow as a result of AF is also something to consider.

I also wonder whether the release of growth factors such as PDGF is more likely increased following CABG surgery.

View all comments by Mary Reid


  Comment by:  Mary Reid
Submitted 13 October 2005  |  Permalink Posted 18 October 2005

Rubinow et al. (1) find that amyloid fibrils bind digoxin and that this may explain the sensitivity to digitalis for some with amyloid cardiomyopathy. Does digoxin bind cerebral amyloid fibrils, and, if so, might this suggest that digoxin therapy is contraindicated for those with AD?

It would be interesting to see whether there is an increased risk of AD for those in the Berendes et al. study (2), which reports increased digoxin levels for some critically ill patients who were not receiving treatment with cardiac glycosides.

References:
1. Rubinow A, Skinner M, Cohen AS. Digoxin sensitivity in amyloid cardiomyopathy. Circulation. 1981 Jun;63(6):1285-8. Abstract

2. Berendes E, Cullen P, Van Aken H, Zidek W, Erren M, Hubschen M, Weber T, Wirtz S, Tepel M, Walter M. Endogenous glycosides in critically ill patients. Crit Care Med. 2003 May;31(5):1331-7. Abstract

View all comments by Mary Reid

  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad